Lexicon Pharmaceuticals Ownership | Who Owns Lexicon Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Lexicon Pharmaceuticals Ownership Summary

Lexicon Pharmaceuticals is owned by 73.41% institutional investors, 1.15% insiders, and 25.44% retail investors. Artal group is the largest institutional shareholder, holding 37.67% of LXRX shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 5.64% of its assets in Lexicon Pharmaceuticals shares.

LXRX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Lexicon Pharmaceuticals	73.41%	1.15%	25.44%
Sector	Healthcare Stocks	279.19%	10.62%	-189.81%
Industry	Biotech Stocks	63.96%	10.74%	25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Artal group	136.18M	37.67%	$100.77M
Fmr	51.97M	14.38%	$38.38M
Siren	38.92M	10.77%	$28.80M
Blackrock	9.89M	4.03%	$16.62M
Blackrock funding, inc. /de	10.33M	2.86%	$7.63M
Vanguard group	9.88M	2.73%	$7.30M
Schonfeld strategic advisors	7.56M	2.09%	$5.58M
Nantahala capital management	6.60M	1.83%	$4.88M
Geode capital management	3.52M	0.97%	$2.60M
State street	2.31M	0.94%	$3.89M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Artal group	136.18M	8.59%	$100.77M
Siren	38.92M	1.27%	$28.80M
Nantahala capital management	6.60M	0.21%	$4.88M
Ikarian capital	1.55M	0.16%	$1.14M
Tang capital management	850.27K	0.04%	$627.92K
Schonfeld strategic advisors	7.56M	0.03%	$5.58M
Cvi	20.00K	0.03%	$33.60K
Hennion & walsh asset management	863.25K	0.03%	$637.51K
Bbr partners	470.00K	0.02%	$347.10K
Pinnacle associates	1.43M	0.01%	$1.05M

Top Buyers

Holder	Shares	% Assets	Change
Schonfeld strategic advisors	7.56M	0.03%	5.68M
Nantahala capital management	6.60M	0.21%	4.30M
Blackrock	9.89M	0.00%	2.20M
Fmr	51.97M	0.00%	2.10M
Vanguard group	9.88M	0.00%	1.79M

Top Sellers

Holder	Shares	% Assets	Change
Orbimed advisors	-	-	-11.02M
Point72 asset management	-	-	-8.99M
Nea management company	-	-	-2.38M
Ameriprise financial	-	-	-2.33M
Opaleye management	-	-	-1.88M

New Positions

Holder	Shares	% Assets	Change	Value
Ikarian capital	1.55M	0.16%	1.55M	$1.14M
Boothbay fund management	480.82K	0.01%	480.82K	$355.09K
Group one trading	314.40K	0.00%	314.40K	$232.19M
Renaissance	51.14K	0.00%	51.14K	$37.77K
Cambridge investment research advisors	23.61K	0.00%	23.61K	$17.00K

Sold Out

Holder	Change
Federated hermes	-6.00
Capital performance advisors llp	-18.00
Tortoise investment management	-21.00
Nelson, van denburg & campbell wealth management group	-21.00
Coppell advisory solutions	-52.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	130	-1.52%	265,798,118	-10.70%	73	1.08%	66	-5.71%	33	32.00%
Dec 31, 2024	122	-12.23%	294,769,499	2.13%	81	1.28%	68	-2.86%	20	-4.76%
Sep 30, 2024	138	6.15%	288,617,050	3.46%	79	0.62%	70	-2.78%	21	-8.70%
Jun 30, 2024	130	6.56%	278,967,822	61.45%	113	1.86%	72	9.09%	23	-20.69%
Mar 31, 2024	122	10.91%	172,789,084	-5.49%	78	1.40%	66	17.86%	29	26.09%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl O	20.40M	5.64%	2.23M
Fidelity Growth Compy Commingled Pl S	14.96M	4.12%	-9.65M
Fidelity Growth Company Fund	10.16M	2.80%	-6.70M
Vanguard Total Stock Mkt Idx Inv	5.15M	1.42%	-
Vanguard US Total Market Shares ETF	3.89M	1.08%	-
Fidelity Select Biotechnology	3.30M	0.91%	2.66M
Fidelity Growth Company K6	3.28M	0.90%	-2.12M
iShares Russell 2000 ETF	2.94M	0.81%	1.44K
Vanguard Institutional Extnd Mkt Idx Tr	2.90M	0.80%	-
Fidelity Series Growth Company	2.47M	0.68%	-1.68M

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	-

LXRX Ownership FAQ

Who Owns Lexicon Pharmaceuticals?

Lexicon Pharmaceuticals shareholders are primarily institutional investors at 73.41%, followed by 1.15% insiders and 25.44% retail investors. The average institutional ownership in Lexicon Pharmaceuticals's industry, Biotech Stocks , is 63.96%, which Lexicon Pharmaceuticals exceeds.

Who owns the most shares of Lexicon Pharmaceuticals?

Lexicon Pharmaceuticals’s largest shareholders are Artal group (136.18M shares, 37.67%), Fmr (51.97M shares, 14.38%), and Siren (38.92M shares, 10.77%). Together, they hold 62.81% of Lexicon Pharmaceuticals’s total shares outstanding.

Does Blackrock own Lexicon Pharmaceuticals?

Yes, BlackRock owns 4.03% of Lexicon Pharmaceuticals, totaling 9.89M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 16.62M$. In the last quarter, BlackRock increased its holdings by 2.2M shares, a 28.56% change.

Who is Lexicon Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Artal group is Lexicon Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 8.59% of its assets in 136.18M Lexicon Pharmaceuticals shares, valued at 100.77M$.

Who is the top mutual fund holder of Lexicon Pharmaceuticals shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of Lexicon Pharmaceuticals shares, with 5.64% of its total shares outstanding invested in 20.4M Lexicon Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools